BOPA ‘Above & Beyond’ Award – nominations OPEN for 2025!

The ‘Above and Beyond’ Award is to celebrate those achievements of BOPA members that often go unnoticed. We want to celebrate colleagues who deserve recognition for how hard they work for patients and colleagues and invite you all to give us your nominations.

Why you decide to nominate is really up to you. You may want to acknowledge a colleague who has implemented an innovative project; you may work with someone who is an exceptional team player; there maybe someone in your team who you consider a fantastic role model. We encourage creativity, and nominations can be made for either an individual colleague, or for a team. This is your opportunity to showcase the work of your hardworking pharmacy colleagues, and tell BOPA all about them.

To nominate and for further information please complete the following form, providing up to 500 words to outline why your nomination should be considered for the ‘Above and Beyond’ Award. We look forward to reading all about them.

Deadline for this years ‘Above and beyond’ Nomination:  31st July 2025

The ‘Above & Beyond’ Award will be presented at our awards ceremony on the Saturday evening of our BOPA Conference in Belfast in October.

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article